Iovance

KEI Comments on NIH Exclusive License to Iovance for T-cell Vaccine for Cancer Treatment

Posted on by Claire Cassedy

On December 17, 2025, Knowledge Ecology International (KEI) provided comments to the National Institutes for Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Vaccine Augmented Tumor Infiltrating Lymphocytes for the Treatment of Cancer” (89 FR 95224) to… Continue Reading →

KEI Comments on NIH Proposed Exclusive License to Iovance for Cancer Cell Therapy

Posted on by Claire Cassedy

On Friday March 12, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy” (86 FR 11548). The technology is… Continue Reading →